Invasive candidiasis due to Candida norvegensis in a liver transplant patient: case report and literature review

Abstract

<em>Candida norvegensis</em> is an emerging fluconazole-resistant pathogen isolated in most cases from skin and mucous membranes of immunocompromized patients. Documented invasive candidiasis (IC) due to<em> C. norvegensis</em> has been rarely reported, thus the clinical features of patients at risk for this pathogen are poorly defined. We report a liver transplant patient who developed IC due to C. norvegensis and review other cases of<em> C. norvegensis</em> IC published in the literature.